Skip to main content
|

Add a bookmark to get started

Bookmarks info
Nur Kara

Nur Kara

Associate
Boston
About

Nur represents pharmaceutical, medical device, and biotechnology companies in a variety of litigation matters, including multi-jurisdictional product liability litigation, complex commercial litigation, and trial work-up. She also works on matters involving regulatory, compliance, and risk management for life science companies. She has experience across the litigation life cycle through trial, including fact and expert witness development, drafting discovery and dispositive motions, taking depositions, and overall case management.

As an alum of the firm’s Krantz Fellowship, Nur devotes substantial time to global pro bono matters and project development for the firm’s non-profit affiliate, New Perimeter. She works on several impact litigation matters concerning special education, disability, and prisoners’ rights; represents survivors of domestic violence seeking restraining orders in district court and immigrant clients seeking humanitarian relief before the Boston Immigration Court and U.S. Citizenship and Immigration Service; and leads multi-country research efforts with international non-profits. 

Nur is also a member of the Boston office’s Diversity & Inclusion Steering Committee and the South Asian Bar Association of Greater Boston’s Board.

Areas of FocusLitigation, Arbitration and Investigations
Bar admissionsMassachusetts

EXPERIENCE

Representative of her experience are the following matters:

  • In re Zantac (Ranitidine) Products Liability Litigation, MDL 2924 (S.D. Fla.): Represents Sanofi in MDL and related state court litigations involving thousands of cancer claims and third party payor, medical monitoring, and consumer fraud class actions. Appointed by MDL Court to Leadership Development Committee.
  • Represents medical device manufacturer in MDL and related state court litigations concerning a patient warming device, achieving a recent defense verdict at trial
  • Represents pharmaceutical manufacturer in COVID-19 vaccine litigation in federal court
  • Represents agrochemical manufacturer in state court product liability litigations through trial
  • Represents pharmaceutical company in product liability matters involving estrogen hormone therapy
  • Represents medical device manufacturer in MDL and related state court litigations concerning hernia mesh devices
  • Advises biotechnology companies on litigation risk mitigation and compliance related to adverse events, promotional, and cGMP regulations
  • The Georgia Advocacy Office, et al. v. State of Georgia, et al., 1:17-cv-03999-MLB (N.D. Ga.): Represents students with intellectual and behavioral needs in proceedings against state-funded program relating to ADA violations and segregation
Education
  • J.D., University of North Carolina School of Law 2020
    Executive Editor, Journal of International Law
    President, Health Law Organization

  • M.Sc., Health Policy, Planning & Financing, London School of Economics & Political Science and London School of Hygiene & Tropical Medicine 2017

  • B.A., University of Chicago 2014

Publications

Media Mentions

EXTERNSHIP AND PRIOR RELEVANT EXPERIENCE

During law school, Nur externed with GlaxoSmithKline Plc. and Harvard Law School’s Center for Health Law and Policy Innovation. She is a former Fulbright-Nehru Scholar and ABA Legal Opportunity Scholar. 

My latest insights

Publication
Abstract building

Fortifying ourselves for 2023: Six key takeaways from DLA Piper’s D&I Product Liability...

1 November 2022 .6 minute read

Connect

Phone

+1 617 406 6091
(Work, Boston)
CallvCardLinkedInPrint
Legal noticesPrivacy policyCookie policyModern slaverySitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA piper's structure, please refer the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2023 DLA Piper